Search research articles
Contact Us
Filters
Showing results (1-10 of 100) with videos related to
Page
of 10
Sort By:
NPJ Genomic Medicine
|
March 5, 2021
Will better evidence on clinical utility bring about greater use of (genetic) tests?
Chris Hyde
Pharmacoeconomics
|
February 8, 2006
How much is the cost of visual impairment: caveat emptor
Catherine Meads, Chris Hyde
Lancet (London, England)
|
May 16, 2003
Combined salmeterol and fluticasone for COPD
Chris Hyde, Janine Dretzke
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
December 3, 2014
Risk of breast cancer in symptomatic women in primary care: a case-control study using electronic records
Sarah Walker, Chris Hyde, William Hamilton
Pharmacoeconomics
|
July 21, 2011
Cautions regarding the fitting and interpretation of survival curves: examples from NICE single technology appraisals of drugs for cancer
Martin Connock, Chris Hyde, David Moore
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
September 4, 2013
Risk of uterine cancer in symptomatic women in primary care: case-control study using electronic records
Sarah Walker, Chris Hyde, William Hamilton
BMJ Open
|
June 25, 2013
Development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes
Jaime L Peters, Rob Anderson, Chris Hyde
Lancet (London, England)
|
September 20, 2005
Putting clinical trials into context
Chris Hyde, Simon Stanworth, Susan Brunskill, et al.
Journal of Clinical Epidemiology
|
December 16, 2021
It was not easy to identify the study design from the title and abstract of articles indexed as diagnostic (test) accuracy studies in EMBASE in 2012 and 2019
Georgina Thompson, Zhivko Zhelev, Harriet Hunt, et al.
BMJ (Clinical Research Ed.)
|
March 30, 2002
Systematic review and meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapy
Rachel Jordan, Lisa Gold, Carole Cummins, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 100) with videos related to
Sort By:
Page
of 10
NPJ Genomic Medicine
|
March 5, 2021
Will better evidence on clinical utility bring about greater use of (genetic) tests?
Chris Hyde
Pharmacoeconomics
|
February 8, 2006
How much is the cost of visual impairment: caveat emptor
Catherine Meads, Chris Hyde
Lancet (London, England)
|
May 16, 2003
Combined salmeterol and fluticasone for COPD
Chris Hyde, Janine Dretzke
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
December 3, 2014
Risk of breast cancer in symptomatic women in primary care: a case-control study using electronic records
Sarah Walker, Chris Hyde, William Hamilton
Pharmacoeconomics
|
July 21, 2011
Cautions regarding the fitting and interpretation of survival curves: examples from NICE single technology appraisals of drugs for cancer
Martin Connock, Chris Hyde, David Moore
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
September 4, 2013
Risk of uterine cancer in symptomatic women in primary care: case-control study using electronic records
Sarah Walker, Chris Hyde, William Hamilton
BMJ Open
|
June 25, 2013
Development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes
Jaime L Peters, Rob Anderson, Chris Hyde
Lancet (London, England)
|
September 20, 2005
Putting clinical trials into context
Chris Hyde, Simon Stanworth, Susan Brunskill, et al.
Journal of Clinical Epidemiology
|
December 16, 2021
It was not easy to identify the study design from the title and abstract of articles indexed as diagnostic (test) accuracy studies in EMBASE in 2012 and 2019
Georgina Thompson, Zhivko Zhelev, Harriet Hunt, et al.
BMJ (Clinical Research Ed.)
|
March 30, 2002
Systematic review and meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapy
Rachel Jordan, Lisa Gold, Carole Cummins, et al.
Page
of 10